newsfilter
← Latest News
ACCESS Newswire·

Petros Pharmaceuticals Successfully Completes Important Study in Effort to Make STENDRA(R) (avanafil) the First Erectile Dysfunction Medication to Achieve OTC Status

Human Factor Study represents important component of FDA requirements for technology to pave way for STENDRA OTC approvalNEW YORK, NY / ACCESSWIRE / December 12, 2023 / Petros Pharmaceuticals, Inc. , a